NCT02983331

Mortality After Endoscopic Retrograde Cholangiopancreatography

Patients With Mortality After Endoscopic Retrograde Cholangiopancreatography

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,471 (actual)
• Sponsor: Gulsah Karaoren · Other Government
• Sex: All
• Age: 42 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility

Detailed description

The investigators retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol (midazolam 0.02 mgkg-1; fentanyl, 1 mgkg-1; propofol 1 mgkg-1) between 2011 and 2016 after approval of local ethics committee of Umraniye Training Hospital.

Conditions

• Cholangiopancreatography, Endoscopic Retrograde
• Mortality
• Deep Sedation

Interventions

Type	Name	Description
PROCEDURE	complications during procedure	patients may have anesthesia related complications during procedure

Timeline

• Start date: 2016-04-01
• Primary completion: 2016-05-01
• Completion: 2016-05-01
• First posted: 2016-12-06
• Last updated: 2016-12-06

Locations

1 site across 1 country: Turkey (Türkiye)